IL6 and acute respiratory distress syndrome: High levels of IL-6 during and after an acute SARS-CoV-2 infection are linked with poor outcomes, such as acute respiratory distress syndrome, myocarditis, endothelial dysfunction, and thrombotic events [31,37,38,39].